Narrow Results

Medicine Without Borders — Care before Business.

The SingaporeMedicine Story.

Healthcare Tourism in Thailand: Pain Ahead?

Medical Tourism: New Trends, New Ethos?

Biofuels: Fact or Fantasy?.

Singapore — The Biopolis of Asia.

Complementary Therapies for Cancer Patients.

Medicine Without Border — Care Before Business.

The SingaporeMedicine Story.

Why in the World Do Patients Travel for Medical Care?

Is Medical Tourism For You? …a Look into the System of Healthcare Abroad

Asia Medical Tourism: First-Rate Healthcare for Sale

Medical Tourism and Clinical Trials: The New Silk Road

Aesthetic Medicine in 2007: Trends and Updates

Clinical Assisted Reproduction in Singapore — Challenges Posed by Medical Tourism and Future Prospects for Growth

Busting the Fear for Breast cancer

AUSTRALIA – AIBN and US Researchers Join Forces.

AUSTRALIA – Harmless Gene Mutation Could Trigger Bowel Cancer.

AUSTRALIA – Australian Researchers Identify Melanoma Genes.

AUSTRALIA – UQ Generates First Australian Swine Flu Vaccine.

CHINA – Molecular Biologists Report New Immune Tolerance Mechanism.

CHINA – H1N1 Patients to Pay for their Own Treatment.

CHINA – China Begins Tests for First H1N1 Flu Vaccines.

INDIA – Stem Cells Could Regenerate Insulin-Secreting Tissues.

INDIA – Ayurveda Drug for Cancer.

INDIA – Global Medical Travel Industry To Grow 15-20% Annually.

JAPAN – Japanese Scientists Unveil Ultra-thin Surgical Patch.

SINGAPORE – US$10.4m Awarded to 8 Clean Energy Research Teams.

SINGAPORE – Strong Biomedical Sector Pulls Singapore Out of Recession.

SINGAPORE – Nanotechnology Combats Fatal Brain Infections.

SINGAPORE – Singapore Doctor Pioneers Concept of Biological Transplant for Bone Cancer.

VIETNAM – Cancer Tops List of Diseases Contracted in Vietnam.

OTHER REGIONS — NORTH AMERICA – U.S. Researchers Map Melon Genome.

OTHER REGIONS — EUROPE – Big Firms said to be Delaying Cheaper Drugs.

OTHER REGIONS — EUROPE – Humans can Give Swine Flu to Pigs.

This chapter deals with the emergence of the market for medical tourism in developing countries. In this case, patients travel from highincome countries to get treatment. The factors that have led to a growth in demand for this industry are discussed. In addition, evidence is provided that this industry is growing. The costs and benefits are outlined of this industry to the medical tourist as well as to citizens in the destination country. This chapter finishes by exploring potential incentives and government regulations that could ensure that the costs and concerns associated with the industry are reduced.